Benzinga··Vandana SinghBiogen Partners With Alloy to Accelerate Antisense Drug Development Pipeline
Biogen partners with Alloy Therapeutics to advance antisense oligonucleotide therapies using the AntiClastic platform for multiple undisclosed disease indications.
SNYAPLSBIIBrare diseasesimmunology